FDA Inspection 1197409 — LifeServe Blood Center
The FDA completed an inspection of LifeServe Blood Center on Feb 1, 2023 in Sioux City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 1, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Sioux City, IA (United States)